Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 19, Issue 2, 2007, Pages 145-150

  Poyurovsky, Michael ^a,b   Faragiae, Sarit ^f   Pashinian, Artashes ^a   Levi, Aya ^a   Viosburd, Alexander ^a   Stryjer, Raphael ^a   Weizmae, Ronit ^c   Fuchs, Camil ^d   Weizman, Abraham ^d,e  

^a Technion Medical School   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c TEL AVIV COMMUNITY MENTAL HEALTH CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e GEHA MENTAL HEALTH CENTER   (Israel)

^f Geha Psychiatric Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALTERNATIVE HYPOTHESIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR COORDINATION; NEUROLOGICAL EVALUATION SCALE; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

EID: 34247469274     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2007.19.2.145     Document Type: Article

References (28)

1. Poyurovsky M, Weizman A, Weizman R: Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs 2004; 18:989-1010
2. Poyurovsky M, Fuchs C, Weizman A: Obsessive-compulsive disorder in patients with first-episode schizophrenia. Am J Psychiatry 1999; 156:1998-2000
3. de Haan L, Hoogenboom B, Beuk N, et al: Obsessive-compulsive symptoms and positive, negative, and depressive symptoms in patients with recent onset schizophrenic disorders. Can J Psychiatry 2005; 50:519-524
4. Fenton WS, McGlashan TH: The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 1986; 143:437-441
5. Berman I, Kalinowski A, Berman SM, et al: Obsessive-compulsive symptoms in chronic schizophrenia. Compr Psychiatry 1995; 36:6-10
6. Lysaker PH, Marks KA, Picone JB, et al: Obsessive and compulsive symptoms in schizophrenia: clinical and neurocognitive correlates. J Nerv Ment Dis 2000; 188:78-83
7. Tibbo P, Warneke L: Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci 1999; 24:15-24
8. Gross-Isseroff R, Hermesh H, Zohar J, et al: Neuroimaging communality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder? World J Biol Psychiatry 2003; 4:129-134
9. Bombin I, Arango C, Buchanan RW: Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull 2005; 31:962-977
10. Browne S, Clarke M, Gervin M, et al: Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med 2000; 30:1433-1441
11. Dazzan P, Murray RM: Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry 2002; 43(suppl): 50-57
12. Bachmann S, Bottmer C, Schroder J: Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 2005; 162:2337-2343
13. Gourion D, Goldberger C, Bourdel MC, et al: Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res 2003; 63:181-187
14. Hollander E, Schiffman E, Cohen B, et al: Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry 1990; 47:27-32
15. Khanna S: Soft neurological signs in obsessive-compulsive disorder. Biol Psychiatry 1991; 29(suppl):442
16. Anderson KE, Savage CR: Cognitive and neurobiological findings in obsessive-compulsive disorder. Psychiatr Clin North Am 2004; 27:37-49
17. Bolton D, Gibb W, Lees A, et al: Neurological soft signs in obsessive compulsive disorder: standardised assessment and comparison with schizophrenia. Behav Neurol 1998; 11:197-204
18. First MB, Spitzer RL, Gibbon M: Structural Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, version 2.0). New York, Biometric Research, New York State Psychiatric Institute, 1995
19. Goodman WK, Price LH, Rasmussen SA, et al: The Yale-Brown Obsessive-Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011
20. Buchanan RW, Heinrichs DW: The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989; 27:335-350
21. Andreasen NC: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1984
22. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
23. Guy W: ECDU Assessment Manual for Psychopharmacology, revised. Department of Health Education and Welfare Publication ADM 76-338. Rockville, MD, National Institute of Mental Health, 1976
24. Simpson GM, Angus JW: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19
25. WHO Collaborating Centre for Drug Statistics Methodology: Anatomical Therapeutical Chemical (ATC) classification index with Defined Daily Doses (DDDs). Norway, WHO Collaborating Centre for Drug Statistics Methodology, 2000
26. Sevinckock L, Akoglu A, Topaloglu B, et al: Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 2004; 58:274-279
27. Keshavan MS, Sanders RD, Sweeney JA, et al: Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 2003; 160:1298-1304
28. Whitty P, Clarke M, Browne S, et al: Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychol Med 2003; 33:1479-1484